文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

新型防喷溅呼吸机管路组件对机械通气患者呼吸机相关性肺炎及多重耐药菌定植预防的效果:一项纳入318例患者的前瞻性随机对照干预研究

[Efficiency of novel splash-proof ventilator circuit component on VAP and the colonization of multiple-drug resistant bacteria prevention in patients undergoing mechanical ventilation: a prospective randomized controlled intervention study with 318 patients].
PubMed 文献 · Zhonghua Wei Zhong Bing Ji Jiu Yi Xue · 2017-01-01
一句话结论新型防喷溅呼吸机管路组件联合密闭式气管内吸引在预防VAP方面与常规密闭式吸引相似,且能降低多重耐药菌定植率并减少费用。

该研究为前瞻性单盲随机平行对照干预研究,纳入2014年1月至2016年5月嘉兴市第一医院ICU的330例重症患者,随机分为开放式气管内吸引组、密闭式气管内吸引组和防喷溅吸引组,分别使用常规呼吸机管路组件、常规密闭式气管内吸引系统和带新型防喷溅管路组件的密闭式气管内吸引系统进行机械通气及吸痰。最终318例纳入分析。结果显示,与开放式吸引组相比,密闭式吸引组和防喷溅吸引组VAP总发生率降低但无统计学差异;开放式吸引组和防喷溅吸引组气道细菌定植率和多重耐药菌定植率均显著低于密闭式吸引组。三组真菌定植率、机械通气时间、ICU住院时间、总住院时间、住院费用及院内预后均无显著差异。结论认为,使用新型防喷溅呼吸机管路组件的密闭式气管内吸引在预防VAP方面与常规密闭式吸引具有相似优势,同时能预防多重耐药菌定植并避免常规密闭式吸引的高价格问题。

要点

  • 与开放式吸引组比较,密闭式吸引组和防喷溅吸引组VAP总发生率分别为20.95%(22/105)、21.90%(23/105)vs. 29.63%(32/108),均无统计学差异(均P>0.05)。
  • 开放式吸引组和防喷溅吸引组气道细菌定植率分别为32.41%(35/108)、28.57%(30/105),均显著低于密闭式吸引组的46.67%(49/105)(均P<0.05)。
  • 开放式吸引组和防喷溅吸引组多重耐药菌定植率分别为20.37%(22/108)、15.24%(16/105),均显著低于密闭式吸引组的39.05%(41/105)(均P<0.05)。
  • 三组真菌定植率分别为开放式4.63%、密闭式3.81%、防喷溅6.67%,无统计学差异(P>0.05)。
  • 与密闭式吸引组比较,开放式吸引组和防喷溅吸引组机械通气时间、ICU住院时间、总住院时间及住院费用均降低但无统计学差异(均P>0.05),院内预后三组无显著差异。

适用人群与场景

  • 2014年1月至2016年5月嘉兴市第一医院ICU收治的330例重症患者,随机分组后最终318例纳入分析。

处置流程与药物剂量

  • 开放式气管内吸引组使用常规呼吸机管路组件进行机械通气和吸痰。
  • 密闭式气管内吸引组使用常规密闭式气管内吸引系统进行机械通气和吸痰。
  • 防喷溅吸引组使用带新型防喷溅呼吸机管路组件的密闭式气管内吸引系统进行机械通气和吸痰。

研究设计与关键结果

  • 研究类型为前瞻性单盲随机平行对照干预研究,纳入330例重症患者,最终318例纳入分析,随机分为开放式气管内吸引组(108例)、密闭式气管内吸引组(105例)和防喷溅吸引组(105例)。
  • VAP总发生率:开放式吸引组29.63%(32/108)vs. 密闭式吸引组20.95%(22/105)vs. 防喷溅吸引组21.90%(23/105),均无统计学差异(均P>0.05);每1000机械通气日VAP感染率分别为23.07、14.56、17.35例。
  • 气道细菌定植率:开放式吸引组32.41%(35/108)、防喷溅吸引组28.57%(30/105)均显著低于密闭式吸引组46.67%(49/105)(均P<0.05)。
  • 多重耐药菌定植率:开放式吸引组20.37%(22/108)、防喷溅吸引组15.24%(16/105)均显著低于密闭式吸引组39.05%(41/105)(均P<0.05)。
  • 真菌定植率:开放式吸引组4.63%、密闭式吸引组3.81%、防喷溅吸引组6.67%,无统计学差异(P>0.05)。
  • 机械通气时间(天):开放式吸引组8.00(4.00, 13.75)、防喷溅吸引组8.00(5.00, 13.00)vs. 密闭式吸引组9.00(5.00, 16.00),无统计学差异(P>0.05)。
  • ICU住院时间(天):开放式吸引组10.00(6.00, 16.00)、防喷溅吸引组11.00(7.00, 19.00)vs. 密闭式吸引组13.00(7.50, 22.00),无统计学差异(P>0.05)。
  • 总住院时间(天):开放式吸引组16.50(9.25, 32.00)、防喷溅吸引组19.00(10.50, 32.50)vs. 密闭式吸引组21.00(10.00, 36.00),无统计学差异(P>0.05);住院费用(万元):开放式吸引组4.95(3.13, 8.62)、防喷溅吸引组5.47(3.84, 9.41)vs. 密闭式吸引组6.52(3.99, 11.02),无统计学差异(P>0.05);院内预后三组无显著差异。

证据类型、等级与局限

  • 证据类型:前瞻性单盲随机平行对照干预研究。
  • 临床试验注册:中国临床试验注册中心,注册号ChiCTR-IOR-16009694。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,使用新型防喷溅呼吸机管路组件的密闭式气管内吸引在预防VAP方面与常规密闭式气管内吸引具有相似优势。
  • 作者认为,新型防喷溅管路组件的密闭式气管内吸引优于常规密闭式气管内吸引,因其能预防多重耐药菌定植并避免常规密闭式吸引的高价格问题。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: To investigate the efficiency of closed tracheal suction system (CTSS) using novel splash-proof ventilator circuit component on ventilator-associated pneumonia (VAP) and the colonization of multiple-drug resistant bacteria (MDR) in patients undergoing mechanical ventilation (MV) prevention.

METHODS: A prospective single-blinded randomized parallel controlled intervention study was conducted. 330 severe patients admitted to the intensive care unit (ICU) of the First Hospital of Jiaxing from January 2014 to May 2016 were enrolled, and they were divided into open tracheal suction group, closed tracheal suction group, and splash-proof suction group on average by random number table. The patients in the three groups used conventional ventilator circuit component, conventional CTSS, and CTSS with a novel splash-proof ventilator circuit component for MV and sputum suction, respectively. The incidence of VAP, airway bacterial colonization rate, MDR and fungi colonization rate, duration of MV, length of ICU and hospitalization stay, and financial expenditure during hospitalization, as well as the in-hospital prognosis were recorded.

RESULTS: After excluding patients who did not meet the inclusion criteria, incomplete data, backed out and so on, 318 patients were enrolled in the analysis finally. Compared with the open tracheal suction group, the total incidence of VAP was decreased in the closed tracheal suction group and splash-proof suction group [20.95% (22/105), 21.90% (23/105) vs. 29.63% (32/108)], but no statistical difference was found (both P > 0.05), and the incidence of VAP infections/1 000 MV days showed the same change tendency (cases: 14.56, 17.35 vs. 23.07). The rate of airway bacterial colonization and the rate of MDR colonization in the open tracheal suction group and splash-proof suction group were remarkably lower than those of closed tracheal suction group [32.41% (35/108), 28.57% (30/105) vs. 46.67% (49/105), 20.37% (22/108), 15.24% (16/105) vs. 39.05% (41/105)] with significantly statistical differences (all P < 0.05). Besides, no significantly statistical difference was found in the fungi colonization rate among open tracheal group, closed tracheal group, and splash-proof suction group (4.63%, 3.81% and 6.67%, respectively, P > 0.05). Compared with the closed tracheal suction group, the duration of MV, the length of ICU and hospitalization stay were shortened in the open tracheal suction group and splash-proof suction group [duration of MV (days): 8.00 (4.00, 13.75), 8.00 (5.00, 13.00) vs. 9.00 (5.00, 16.00); the length of ICU stay (days): 10.00 (6.00, 16.00), 11.00 (7.00, 19.00) vs. 13.00 (7.50, 22.00); the length of hospitalization stay (days): 16.50 (9.25, 32.00), 19.00 (10.50, 32.50) vs. 21.00 (10.00, 36.00)], and financial expenditure during hospitalization was lowered [10 thousand Yuan: 4.95 (3.13, 8.62), 5.47 (3.84, 9.41) vs. 6.52 (3.99, 11.02)] without significantly statistical differences (all P > 0.05). Moreover, no significantly statistical difference was found in the in-hospital prognosis among the three groups.

CONCLUSIONS: CTSS performed using novel splash-proof ventilator circuit component shared similar advantages in preventing VAP with the conventional CTSS. Meanwhile, it is superior because it prevented the colonization of MDR and high price in the conventional CTSS.Clinical Trail Registration Chinese Clinical Trial Registry, ChiCTR-IOR-16009694.

来源:Zhonghua Wei Zhong Bing Ji Jiu Yi Xue,查看原文。版权归原作者所有。

参考来源

  1. Xu S, Yu H, Sun H, et al. [Efficiency of novel splash-proof ventilator circuit component on VAP and the colonization of multiple-drug resistant bacteria prevention in patients undergoing mechanical ventilation: a prospective randomized controlled intervention study with 318 patients]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2017. PMID: 28459397. doi:10.3760/cma.j.issn.2095-4352.2017.01.004

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。